堀口英利の潰瘍性大腸炎の診断書（2023年）の謎

上記にて当院外来にて継続加療中。2023年6月■日再燃のため受診し加療を 開始し、継続するも2023年8月より再度悪化を認め、現時点では9月中旬ま での加療を要する。以下余白。

しかし、申立人は、実際に潰瘍性大腸炎の患者であり、慶応義塾大学病院において臨床調査個人票（甲5-1および甲5-2）のほか診断書を取得している（甲6-1から甲6-3）。

-Medical certificate-

Name: Hr. Hidetoshi Horiguchi
Gender: Mate
008: 16 Mar 1908
To whom it may concern:

This is to inform hesith status and Illness for which above person is now under treatment

Gurrent diseass: Ulcerative colitie
Medication Upadacitinib 45mg
Past medical history: NA

Mr. Hidetoshi Horiguchi first presented persisitent stomach pain and bloody diarrhee on December 2013 He was referred to our hospital on 23 March. We performed colonoscopy and blood test for suspected infi armatory bowel diseases, and diagnosed as ulcerative colitie. Fron 13 April, we praearibed Pentasa 4g/d Several days later, he presantad moderate to severe cramps in the lower abdomen, mucous and bloody di arrhoea, which brought him to oor hospital on 25 April, The blood test results shosed elevated traneasi nase levels, suggesting intolerance to Pontesa e storidoned Pentasa on 27 April due to adversed events of Pentasa and prescribed budesonide foam enans as an induntion therapy. De-sensitization of Asacol (f com 400mg/day) was not successfule due to the recourent abdominal cramps.
After multiple courses of induction of corticosteroid this patient exhibited flaring up in late July 2 023. Ne prescribed upadacitinib on 29 August 2023, but clinical symptoms (frequent bloody diarrhea and abdominal pain substantially affects his quality of daily life.

Date 11 Saptiunter 2023

Physician's signature
Tohel Mikami

Division of Gestroenterology and Hepatology
Deporteent of Internal Medicine
Kalo University School of Medicine